Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$0.61 - $0.98 $5,731 - $9,208
9,396 Added 16.97%
64,750 $46,000
Q4 2022

Feb 13, 2023

SELL
$1.36 - $22.72 $148 - $2,476
-109 Reduced 0.2%
55,354 $81,000
Q3 2022

Nov 14, 2022

BUY
$2.97 - $23.6 $1,562 - $12,413
526 Added 0.96%
55,463 $154,000
Q2 2022

Aug 12, 2022

BUY
$2.81 - $5.5 $2,899 - $5,676
1,032 Added 1.91%
54,937 $202,000
Q1 2022

May 13, 2022

BUY
$3.42 - $6.37 $64,333 - $119,826
18,811 Added 53.6%
53,905 $224,000
Q3 2021

Nov 12, 2021

BUY
$3.23 - $24.73 $113,353 - $867,874
35,094 New
35,094 $355,000

Others Institutions Holding NURO

# of Institutions
1
Shares Held
320
Call Options Held
0
Put Options Held
0

About NeuroMetrix, Inc.


  • Ticker NURO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 7,757,230
  • Market Cap $30.3M
  • Description
  • NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to e...
More about NURO
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.